All In MedTech

FDA Clearance Tracker · K240280

Nano-Check™ RSV Test

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Jul 30, 2024 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Jul 30, 2024

Substantially Equivalent

Time to decision

180 days

Received Feb 1, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Dual Track

Device class

Class I

The decision

FDA number
K240280
Device name
Nano-Check™ RSV Test
Applicant location
Cranbury, NJ
Received
Feb 1, 2024
Decided
Jul 30, 2024
Decision
Substantially Equivalent
Submission type
Dual Track

Device type

Device class
Class I
Regulation
21 CFR 866.3480

Every decision under product code GQG

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code GQG. The earliest in FDA's data is K770804, decided May 20, 1977.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Nano-Ditech Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.